NRX Pharmaceuticals
NRXP
NRXP
25 hedge funds and large institutions have $9.76M invested in NRX Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
4
Closed
2
Calls
$145K
Puts
$18K
Net Calls
+$127K
Net Calls Change
-$177K
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.39M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$396K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$301K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$206K |
| 5 |
Squarepoint
New York
|
+$138K |
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$182K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$75K |
| 3 |
TC
TownSquare Capital
Provo,
Utah
|
-$30.8K |
| 4 |
Morgan Stanley
New York
|
-$24.5K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$522 |
